JBR Clinical Research   Report issue

For profit Phase 2 Phase 3
Founded: Salt Lake City UT United States (1986)

Organization Overview

First Clinical Trial
2018
NCT03852459
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

JBR Clinical Research | JBR Research

Active Ingredients

Drugs in Phase 3 Trials (2)

ibuprofen (motrin) (1 trial)

naproxen (naprosyn) (2 trials)

Drugs in Phase 2 Trials (5)

acetaminophen (tylenol) (1 trial)

av7909 (1 trial)

biothrax (1 trial)

dexibuprofen (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Pain (Phase 2)

Anthrax (Phase 2)

Toothache (Phase 3)

Tooth, Impacted (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 7